The number of unexpected HbA1c variants may be a greater problem in routine practice than is generally realized

Diabetic Medicine

Volumn 21, Issue 9, 2004, Pages 1041-1044

  Reynolds, T M ^a   Twomey, P J ^b   Harvey, T C ^b   Green, B N ^b  

^a QUEEN S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Epidemilogy; Haemoglobin variants; Haemoglobinopathy; HbA1c; HPLC

Indexed keywords

HEMOGLOBIN A1C; HEMOGLOBIN VARIANT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CASE REPORT; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; GEOGRAPHIC DISTRIBUTION; HEMOGLOBIN ANALYSIS; HEMOGLOBINOPATHY; HUMAN; MALE; MASS SPECTROMETRY; POINT MUTATION; PREVALENCE; RISK FACTOR; BLOOD; GENETICS;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; MALE;

EID: 4544228914     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01278.x     Document Type: Article

References (33)

1. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM. American Diabetes Association technical reviews on tests of glycaemia. Diabetes Care 1995; 18: 896-909.
2. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001; 47: 153-163.
3. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436-472.
4. 1c titers detected by different methods. Clin Chem 1998; 44: 1562-1564.
5. Twomey PJ, Reynolds TM, Wierzbicki AS. Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for A1C. Curr Medical Res Opin 2003; 19: 719-721.
6. Massart DL, Diijkstra A, Kaufman L. Evaluation and Optimization of Laboratory Methods and Analytical Procedures: a Survey of Statistical and Mathematical Techniques. Amsterdam: Elsevier, 1978: 157-164.
7. National Glycoprotein Standardization Program (NGSP). Available from: http://web.missouri.edu/~diabetes//ngsp/indexfrs.html (accessed 18 September 2002).
8. Anonymous. International Hemoglobin Information Center variant list. Hemoglobin 1994; 18: 77-183.
9. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mut 2002; 19: 225-233.
10. HbVar: A data base of human haemoglobin variants and thalassaemias. Available from: http://globin.cse.psu.edu/globin/hbvar/menu.html (accessed 21 November 2002).
11. Clarke GM, Higgins TF. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem 2000; 46: 1284-1290.
12. Harvey D, Reynolds T. Serendipity and glycated haemoglobin assay: discovery of a new haemoglobin variant. Ann Clin Biochem 1995; 32: 325.
13. 1c. Blood 1995; 86: 647a.
14. 1c in diabetes mellitus: structure, function, DNA sequence. Mayo Clinic Proc 1998; 73: 321-328.
15. 1c values. Hemoglobin 2000; 24: 163-164.
16. Paseska-Karanfilska D, Song KS, Efremov GD. Haemoglobin Old Dominion/Burton-upon-Trent, or [β143 (H21) His → Tyr] found in a diabetic woman from Korea. Hemoglobin 2000; 24: 323-326.
17. Reynolds TM, McMillan F, Smith A, Hutchinson A, Green B. Haemoglobin Le Lamentin (α20 (B1) His → Gln) in a British family: identification by electrospray mass spectrometry. J Clin Path 1998; 51: 467-470.
18. Sellaye M, Blouquit Y, Galacteros F, Arous N, Monplaisir N, Rhoda M et al. A new silent haemoglobin variant in a black family from French West Indies: Haemoglobin Le Lamentin α20 His → Gln. FEBS Lett 1983; 145: 128-130.
19. Harano T, Harano K, Shibata S, Ueda S, Imai K, Tsuneshige A et al. Hb Le Lamentin (α20 (B1) His → Gln) in Japan: structure, function and biosynthesis. Hemoglobin 1983; 7: 181-184.
20. β2 found in a Spanish family. Hemoglobin 1988; 12: 201-205.
21. Wiener K, McFarlane X, Green BN. Increasing recognition of Haemoglobin Le Lamentin. J Clin Path 2001; 54: 970.
22. Reynolds TM, Harvey TC, Green BN, Smith A, Giles P. Haemoglobin Wayne in a British Family: identification by electrospray mass spectrometry. Clin Chem 2002; 48: 2261-2263.
23. Huisman TH, Headlee MG, Wilson JB, Lam H, Johnson SE, Webber BB. Hb Wayne, the frameshift variant with extended α chains observed in a Caucasian familify from Michigan. Hemoglobin 1984; 8: 1-15.
24. Seid-Akhavan M, Winter WP, Abramson RK, Rucknagel DL. Hemoglobin Wayne: a frameshift mutation detected in human hemoglobin alpha chains. Proc Natl Acad Sci USA, 1976; 73: 882-886.
25. Salkie ML, Higgins T, Morrison DM, Wilson JB, Gu LH, Curuk MA et al. A Canadian family with Hb Wayne; characterization by HPLC and DNA sequencing. Hemoglobin 1992; 16: 515-519.
26. Schnedl WJ, Lipp RW, Trinker M, Hopmeier P. Hemoglobin D [beta 121(GH4)Glu → Gln] causing falsely low and high HbA1c values in HPLC. Clin Chem 1998; 44: 1999-2000.
27. Jones JP. History of the South Staffordshire Regiment, 1705-1923. Wolverhampton: Whitehead Bros, 1923.
28. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycated hemoglobin. Clin Chem 2001; 47: 153-163.
29. Frank EL, Moulton L, Little RR, Wiedmeyer HM, Rohlfing C, Roberts WL. Effects of haemoglobin C and S traits on seven glycohemoglobin methods. Clin Chem 2000; 46: 864-867.
30. 1c determinations in patients with hemoglobinopathies. Diabetes Care 1999; 22: 368-369.
31. Talwar D, Barr BB, Kesson CM. Robb DA. Determination of glycosylated adult and foetal haemoglobins by affinity chromatography. Clin Chem Acta 1983; 128: 61-67.
32. 1c by ion-exchange chromatography. Clin Chem Acta 1990; 191: 239-244.
33. Chen D, Crimmins DL, Hsu FF, Lindberg FP, Scott MG. Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A1C in an automated ion-exchange HPLC method. Clin Chem 1998; 44: 1296-1301.